By blocking the JAK2/STAT3 signaling pathway, ATL I has also been demonstrated to decrease cell viability, induce apoptosis, and impede cell migration in human melanoma cells A375, as well as down-regulate the levels of STAT3 target genes Bcl-xL, MMP-2, and MMP-9 [52]. This evidence concerns the gene BCL2L1 and melanoma.